I was concerned about the BNC210 Phase 2 Agitation in the Elderly clinical trial. Says in the Quarterly that enrolment had slowed. I thought it was close to data readout. I emailed the CFO, his response:
BNO Price at posting:
10.8¢ Sentiment: Hold Disclosure: Held